|
|
Volumn 11, Issue 2, 2002, Pages 295-302
|
|
Sublingual apomorphine for the treatment of erectile dysfunction
|
|
Author keywords
Apomorphine; Erectile dysfunction; Hypothalamus sublingual
|
|
Indexed keywords
ANTIEMETIC AGENT;
APOMORPHINE;
DOPAMINE;
NEUROTRANSMITTER;
NEW DRUG;
NITRIC OXIDE;
OXYTOCIN;
PHOSPHODIESTERASE INHIBITOR;
PLACEBO;
SEROTONIN;
SILDENAFIL;
DOPAMINE RECEPTOR STIMULATING AGENT;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DOSE TIME EFFECT RELATION;
DRUG EFFECT;
DRUG MARKETING;
DRUG SOLUBILITY;
DRUG STRUCTURE;
ERECTILE DYSFUNCTION;
FIRST PASS EFFECT;
FOOD DRUG INTERACTION;
HEADACHE;
HUMAN;
HYPOTHALAMUS;
MALE;
NAUSEA;
PENIS ERECTION;
PHASE 3 CLINICAL TRIAL;
PREVALENCE;
PRIMARY HEALTH CARE;
SEXUALITY;
SOCIAL PSYCHOLOGY;
SYNCOPE;
TREATMENT FAILURE;
VERTIGO;
COMPARATIVE STUDY;
IMPOTENCE;
PSYCHOLOGICAL ASPECT;
REVIEW;
SUBLINGUAL DRUG ADMINISTRATION;
TIME;
ADMINISTRATION, SUBLINGUAL;
APOMORPHINE;
CLINICAL TRIALS;
DOPAMINE AGONISTS;
HUMANS;
IMPOTENCE;
MALE;
PENILE ERECTION;
TIME FACTORS;
|
|
EID: 0036172120
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.11.2.295 Document Type: Article |
|
Times cited : (22)
|
|
References (22)
|
